Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2000, p. 1276-1278, Vol. 38, No. 3
Department of Medicine and Epidemiology,
School of Veterinary Medicine, University of California, Davis,
California 956161; Division of Medical
Microbiology, The Johns Hopkins Medical Institutions, Baltimore,
Maryland 212872; and Department of
Veterinary Internal Medicine, University of Zurich, CH-8057 Zurich,
Switzerland3
Received 3 September 1999/Returned for modification 10 December
1999/Accepted 24 December 1999
We report the successful infection throughout intravenous
inoculation with low and high passage of in vitro-grown human
granulocytic ehrlichiosis (HGE) agent in horses. Differences in disease
severity but not in incubation time, hematological changes, PCR
detection, ehrlichial load, seroconversion time, and titer range were
noted between horses infected with a low and a high passage of in
vitro-grown HGE agent.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Experimental Inoculation with Human Granulocytic
Ehrlichia Agent Derived from High- and Low-Passage Cell Culture
in Horses
*
Corresponding author. Mailing address: School of
Veterinary Medicine, University of California, Davis, CA 95616. Phone:
(530) 752-2371. Fax: (530) 752-0414. E-mail:
npusterla{at}ucdavis.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»